Cancer clinical trials in the region Hauts-de-France
105 currently recruiting clinical trials
If you are a doctor and would like find matching clinical trials for you patients, create an account or log in
If you are a patient and would like to know if you may participate in a clinical trial, please consult your doctor so that he can send your file to a matching trial
Phase 2
Lung cancer
#NCT04143711
NSCLC (Non-Small Cell Lung Cancer)
Locally Advanced
Metastatic
HER2
Immunotherapy
Chemotherapy
Systemic Treatment-Naive
Groupe Hospitalier Saint André (Bordeaux), Centre Oscar Lambret (Lille), Centre Léon Bérard (Lyon), Institut Paoli-Calmettes (Marseille), Institut Curie - Paris (Paris) (and 2 more...)
Dragonfly Therapeutics
Phase 2
Lymphoma
#NCT03888105
B cell lymphoma
Large B cell lymphoma
Primary mediastinal lymphoma
Mantel cell lymphoma
Follicular lymphoma
Marginal zone lymphoma
MALT lymphoma
Lymphocytic lymphoma
Indolent transformed lymphoma
None
2
3 or more
Systemic Treatment-Naive
Car-T
Bispecific T-cell engager antibodies
Allogeneic stem cell transplant
CHU Caen Normandie (Caen), Hôpital Saint Louis AP-HP (Paris), CHU - Haut-lévêque - Bordeaux (Pessac), Centre Hospitalier Universitaire de Poitiers - Site de la Milétrie (Poitiers), Hôpital Henri-Mondor AP-HP (Créteil) (and 4 more...)
Regeneron Pharmaceuticals
Phase 2
Lymphoma
#NCT03703050
T cell lymphoma
Peripheral T cell lymphoma
Chemotherapy
Targeted therapy
Antibody Drug Conjugates (ADC)
1
Systemic Treatment-Naive
Hôpital Claude Huriez (Lille), Gustave Roussy (Villejuif), CHU - Haut-lévêque - Bordeaux (Pessac), Centre Léon Bérard (Lyon), IUCT Oncopôle (Toulouse) (and 5 more...)
Gustave Roussy, Campus du cancer, Grand Paris
Phase 2
Prostate cancer
#NCT03438552
Adenocarcinoma
Biochemical recurrence
Radiotherapy
Systemic Treatment-Naive
Immunotherapy
Chemotherapy
Car-T
Bispecific T-cell engager antibodies
Antibody Drug Conjugates (ADC)
Centre François Baclesse (Caen ), CGFL Dijon - Centre Régional De Lutte Contre Le Cancer Georges - François Leclerc (Dijon ), Centre Jean Perrin (Clermont Ferrand ), Institut du cancer de Montpellier (Montpellier), Centre Oscar Lambret (Lille) (and 6 more...)
UNICANCER
Phase 2
Kidney cancer
#NCT03175224
Locally Advanced
Metastatic
Other mutation
Centre Hospitalier Universitaire de Lille (Lille), Centre Léon Bérard (Lyon), CHU de Rennes - Hôpital Pontchaillou (Rennes), Gustave Roussy (Villejuif), Hôpital de la Timone AP-HM (Marseille) (and 2 more...)
Apollomics
Phase 2
Lung cancer
#NCT03175224
NSCLC (Non-Small Cell Lung Cancer)
Locally Advanced
Metastatic
EGFR
MET
Targeted therapy
BRAF
ALK
RET
ROS-1
NTRK-1/2/3
KRAS G12C
KRAS non G12C
Systemic Treatment-Naive
Centre Hospitalier Universitaire de Lille (Lille), Centre Léon Bérard (Lyon), CHU de Rennes - Hôpital Pontchaillou (Rennes), Gustave Roussy (Villejuif), Hôpital de la Timone AP-HM (Marseille) (and 2 more...)
Apollomics
Phase 2
Colon cancer
Rectal cancer
#NCT05310643
Adenocarcinoma
Metastatic
MSI/dMMR
Chemotherapy
Targeted therapy
MSS
Hôpital Saint Antoine AP-HP (Paris), Centre Hospitalier Universitaire de Lille - Institut Cœur Poumon (Lille)
GERCOR - Groupe Coopératif Multidisciplinaire d'Oncologie
Phase 2
Colon cancer
Rectal cancer
#NCT04262687
Metastatic
MSS
Systemic Treatment-Naive
MSI/dMMR
Immunotherapy
Immunotherapy
Hôpital Privé Arnault Tzanck Mougins Sophia Antipolis (Mougins), Hôpital Européen de Marseille (Marseille), Centre hospitalier Intercommunal Mont-de-Marsan - Pays des Sources (Mont-de-Marsan), CHU de Rennes - Hôpital Pontchaillou (Rennes), Institut de Cancérologie Radiothérapie Brétillien / CHP Saint Grégoire - Vivalto Santé (Saint-Grégoire) (and 54 more...)
Fédération Francophone de Cancérologie Digestive
Phase 2
Lung cancer
#NCT03175224
Locally Advanced
Metastatic
MET
EGFR
BRAF
ALK
RET
ROS-1
NTRK-1/2/3
KRAS G12C
KRAS non G12C
Systemic Treatment-Naive
Targeted therapy
Centre Hospitalier Universitaire de Lille (Lille), Centre Léon Bérard (Lyon), CHU de Rennes - Hôpital Pontchaillou (Rennes), Gustave Roussy (Villejuif), Hôpital de la Timone AP-HM (Marseille) (and 2 more...)
Apollomics
Phase 2
Lung cancer
#NCT03175224
NSCLC (Non-Small Cell Lung Cancer)
Locally Advanced
Metastatic
MET
Systemic Treatment-Naive
Immunotherapy
Chemotherapy
EGFR
BRAF
ALK
RET
ROS-1
NTRK-1/2/3
KRAS G12C
KRAS non G12C
Targeted therapy
Centre Hospitalier Universitaire de Lille (Lille), Centre Léon Bérard (Lyon), CHU de Rennes - Hôpital Pontchaillou (Rennes), Gustave Roussy (Villejuif), Hôpital de la Timone AP-HM (Marseille) (and 2 more...)
Apollomics